Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Medical - Devices

Healthcare
$103.32 +1.00%

+$0.87 today

Market cap
$19.55B
Beta
0.47
P/E (TTM)
22.5
EPS (TTM)
$3.90
Dividend yield
1.09%
52W Low $79.12High $108.29

Volume 2.34M

Average 2.28M

ZBH Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

Zimmer Biomet Holdings, Inc.NYSE: ZBH

Other Non-Cash Items · Q2 FY2026 · quarter ended Jun 2026

Other non-cash items turns negative

Q2 FY2026 other non-cash items was -$100K, compared with $0 a year earlier. Trailing-twelve-month other non-cash items was -$152.1M. Over 3 fiscal years it compounded at -93.3% a year.

Context

  • Other non-cash items amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Other non-cash items increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly other non-cash items holds near -$100K or moves back toward the trailing-twelve-month quarterly average of -$38.02M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$100K-150.0% QoQ
Last fiscal yearDec 2025
$100K— YoY
LTMJun 2026
-$152.1M+219.5% YoY
Other Non-Cash Items past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR-93.3%——
5-year CAGR——
10-year CAGR——

Other Non-Cash Items history

USD · from the cash flow

Latest · FY2025
100K USD
Year-over-year change
—
4-year CAGR
-86.2%

Other Non-Cash Items vs competitors

How ZBH compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +219.5% is the 2nd highest of 10, against a peer median of +21.9%.
  • Other non-cash items amounts to 1.8% of revenue for ZBH, versus a peer median of 2.1%.
ZBH Competitors
Other Non-Cash Items for ZBH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$1.69B USD+21.9%-13.8%8.3%
SYKStryker CorporationLTM Jun 2026$537M USD-145.4%—2.1%
MDTMedtronic plcLTM Jul 2026$352M USD+126.2%+4.4%0.9%
EWEdwards Lifesciences CorporationLTM Jun 2026$296.7M USD+108.9%+18.1%4.6%
ALGNAlign Technology, Inc.LTM Jun 2026$290.91M USD-19.4%+4.7%7.0%
PHGKoninklijke Philips N.V.LTM Jun 2026€243.59M EUR+262.6%-34.3%1.4%
BSXBoston Scientific CorporationLTM Jun 2026$207M USD+15.6%-25.5%1.0%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$152.1M USD+219.5%-93.3%1.8%
OFIXOrthofix Medical Inc.LTM Mar 2026$117.54M USD+89.8%—14.2%
SNNSmith & Nephew plcFY2025$11M USD-89.3%-59.6%0.2%
Peer median (excluding ZBH) —+21.9%-13.8%2.1%

Competitors are the stored peer set for ZBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income445.5M291.2M1.03B905.2M705.1M
Depreciation & Amortization937.7M926.4M951.7M996.3M1.09B
Deferred Income Tax(102.1M)(64.4M)(96.3M)(47.7M)(87.2M)
Stock-Based Compensation76M105M99.8M101M90.2M
Change in Working Capital(134.2M)(311.4M)(396.2M)(455.4M)(104.9M)
Accounts Receivables(40.8M)(184.7M)(51.9M)(89.7M)(127.3M)
Inventory(8.4M)(75.6M)(240.4M)49.9M98.2M
Accounts Payables86.5M103M(55.3M)(322M)101.8M
Other Working Capital(171.5M)(154.1M)(48.6M)(93.6M)(177.6M)
Other Non-Cash Items276.3M337.9M(2.5M)0100K
Operating Cash Flow1.5B1.28B1.58B1.5B1.7B
Capital Expenditures(152M)(217.6M)(394.5M)(356.8M)(224.5M)
Acquisitions (Net)0(99.8M)(134.9M)(276.3M)(1.39B)
Purchases of Investments(273.6M)(258.3M)(311.7M)(240.3M)(300.5M)
Sales of Investments1.9M89.4M33.4M22.1M0
Other Investing Activities(88.3M)(72.6M)(74.6M)(189.8M)(57.5M)
Investing Cash Flow(503.6M)(529.2M)(778.9M)(888.1M)(1.98B)
Debt Repayment(1.06B)(1.06B)54.6M536.3M1.03B
Common Stock Issued122.5M00039.7M
Common Stock Repurchased0(126.4M)(692.2M)(868M)(487M)
Dividends Paid(200.1M)(201.2M)(200.9M)(196M)(190.3M)
Other Financing Activities(173.4M)544.5M75M43.2M(65.5M)
Financing Cash Flow(1.31B)(843.8M)(763.5M)(484.5M)326M
Effect of Forex Changes(13.2M)(14.5M)900K(17.1M)19M
Net Change in Cash(323.6M)(102.8M)40.1M109.7M66.4M
Free Cash Flow1.35B1.07B1.19B1.14B1.47B

Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Intrinsic Alpha fair value

Locked

Current Price

$103.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.